About Nuvation Bio (NUVB)
Nuvation Bio Inc. operates as a bio-pharmaceutical company. The Company focuses on developing oncology medicines that will improve patient lives by addressing drug resistance. Nuvation Bio serves patients worldwide.
- USD3.24
- USD3.25
- USD3.17
- USD4.16
- -11.30%
- --
- 456.41k
- 1.27M
- 791M
- 0.95
- 101.30%
Stock News
2 hours ago
AI Powers This IBD 50 Logistics Leader; Sales Look To Soar 90%
Yahoo
2 hours ago
Jim Cramer Says “Hang On To Stocks” and Recommends 10 Stocks
Yahoo
2 hours ago
Intel Claims It's On Track To Catch Up By 2026 Despite A Lackluster Outlook
Yahoo
3 hours ago
We are trimming a large position to take some profits in this overbought market
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
